Cargando…
Sorafenib and triptolide loaded cancer cell-platelet hybrid membrane-camouflaged liquid crystalline lipid nanoparticles for the treatment of hepatocellular carcinoma
In addition to early detection, early diagnosis, and early surgery, it is of great significance to use new strategies for the treatment of hepatocellular carcinoma (HCC). Studies showed that the combination of sorafenib (SFN) and triptolide (TPL) could reduce the clinical dose of SFN and maintain go...
Autores principales: | Li, Zhe, Yang, Gang, Han, Lu, Wang, Rong, Gong, Chunai, Yuan, Yongfang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576878/ https://www.ncbi.nlm.nih.gov/pubmed/34749742 http://dx.doi.org/10.1186/s12951-021-01095-w |
Ejemplares similares
-
The effects of triptolide on the pharmacokinetics of sorafenib in rats and its potential mechanism
por: Wang, Xianming, et al.
Publicado: (2017) -
Biomimetic platelet-camouflaged drug-loaded polypyrrole for the precise targeted antithrombotic therapy
por: Zhao, Zhining, et al.
Publicado: (2023) -
Platelet-Tumor Cell Hybrid Membrane-Camouflaged Nanoparticles for Enhancing Therapy Efficacy in Glioma
por: Wu, Lingling, et al.
Publicado: (2021) -
Hybrid Lipid Nanoformulations for Hepatoma Therapy: Sorafenib Loaded Nanoliposomes—A Preliminary Study
por: Bartos, Adrian, et al.
Publicado: (2022) -
Lipid nanoparticles loading triptolide for transdermal delivery: mechanisms of penetration enhancement and transport properties
por: Gu, Yongwei, et al.
Publicado: (2018)